Survivorship considerations in adults with hereditary breast and ovarian cancer syndrome: state of the science (Q37376122)

20 August 2017

1 reference

title

Survivorship considerations in adults with hereditary breast and ovarian cancer syndrome: state of the science (English)

1 reference

20 August 2017

1 reference

Cheryl B Crotser

1 reference

20 August 2017

Marcia Boehmke

series ordinal

1 reference

20 August 2017

publication date

23 January 2009

1 reference

Journal of Cancer Survivorship

20 August 2017

published in

1 reference

20 August 2017

1 reference

20 August 2017

1 reference

20 August 2017

page(s)

21-42

1 reference

Tolerance for uncertainty and perceived risk among women receiving uninformative BRCA1/2 test results

20 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11764-008-0077-7

Psychological impact of genetic testing in women from high-risk breast cancer families

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11764-008-0077-7

Self-regulation theory and coping with physical illness

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11764-008-0077-7

Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample

21 January 2018

1 reference

12 December 2020

Surveillance behavior and prophylactic surgery after predictive testing for hereditary breast/ovarian cancer

1 reference

12 December 2020

Family issues in a psychoeducation group for women with a BRCA mutation

1 reference

12 December 2020

BRCA1/2 testing in hereditary breast and ovarian cancer families II: impact on relationships.

1 reference

12 December 2020

Understanding the experience of prophylactic bilateral mastectomy: a qualitative study of ten women

1 reference

12 December 2020

Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study

1 reference

12 December 2020

Accommodating risk: responses to BRCA1/2 genetic testing of women who have had cancer.

1 reference

12 December 2020

Prophylactic mastectomy for the prevention of breast cancer

1 reference

12 December 2020

Quality of life in breast cancer survivors as identified by focus groups

1 reference

12 December 2020

Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination

1 reference

12 December 2020

The impact of receiving genetic test results on general and cancer-specific psychologic distress among members of an African-American kindred with a BRCA1 mutation

1 reference

12 December 2020

The Theory of Genetic Vulnerability: a Roy model exemplar

1 reference

12 December 2020

Psychosocial effects of living with an increased risk of breast cancer: an exploratory study using telephone focus groups

1 reference

12 December 2020

Stress and genetic testing for disease risk

1 reference

12 December 2020

"Social separation" among women under 40 years of age diagnosed with breast cancer and carrying a BRCA1 or BRCA2 mutation

1 reference

12 December 2020

Genetic testing for hereditary breast and ovarian cancer: responsibility and choice

1 reference

12 December 2020

Results of an intervention for individuals and families with BRCA mutations: a model for providing medical updates and psychosocial support following genetic testing

1 reference

12 December 2020

Women with BRCA1 or BRCA2 mutations renegotiating a post-prophylactic mastectomy identity: self-image and self-disclosure

1 reference

12 December 2020

Familial effects of BRCA1 genetic mutation testing: changes in perceived family functioning

1 reference

12 December 2020

Attitudes about genetic testing and genetic testing intentions in African American women at increased risk for hereditary breast cancer

1 reference

12 December 2020

Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey

1 reference

12 December 2020

Short- and long-term impact of receiving genetic mutation results in women at increased risk for hereditary breast cancer

1 reference

12 December 2020

Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer Clinic

1 reference

12 December 2020

Diagnostic genetic testing for hereditary breast and ovarian cancer in cancer patients: women's looking back on the pre-test period and a psychological evaluation

1 reference

12 December 2020

Impact of BRCA1/2 testing and disclosure of a positive test result on women affected and unaffected with breast or ovarian cancer

1 reference

12 December 2020

Familial context of genetic testing for cancer susceptibility: moderating effect of siblings' test results on psychological distress one to two weeks after BRCA1 mutation testing.

1 reference

12 December 2020

Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programs

1 reference

12 December 2020

Breast cancer survivorship: are African American women considered? A concept analysis

1 reference

12 December 2020

Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: reactions and behavior after the disclosure of a positive test result.

1 reference

12 December 2020

Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCA mutations. Austrian Hereditary Breast and Ovarian Cancer Group

1 reference

12 December 2020

Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer

1 reference

12 December 2020

One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery).

1 reference

12 December 2020

Evaluation of the needs of spouses of female carriers of mutations in BRCA1 and BRCA2

1 reference

12 December 2020

Predictive genetic testing for hereditary breast and ovarian cancer: psychological distress and illness representations 1 year following disclosure

1 reference

12 December 2020

The course of distress in women at increased risk of breast and ovarian cancer due to an (identified) genetic susceptibility who opt for prophylactic mastectomy and/or salpingo-oophorectomy

1 reference

12 December 2020

What is in a cause? Exploring the relationship between genetic cause and felt stigma

1 reference

12 December 2020

Toward a biopsychosocial model for 21st-century genetics

1 reference

12 December 2020

Quality of life after contralateral prophylactic mastectomy in newly diagnosed high-risk breast cancer patients who underwent BRCA1/2 gene testing

1 reference

12 December 2020

A multicenter study of supportive-expressive group therapy for women with BRCA1/BRCA2 mutations

1 reference

12 December 2020

Who is prone to high levels of distress after prophylactic mastectomy and/or salpingo-ovariectomy?

1 reference

12 December 2020

A prospective study of the impact of genetic susceptibility testing for BRCA1/2 or HNPCC on family relationships

1 reference

12 December 2020

Changes in psychological distress after cancer genetic counselling: a comparison of affected and unaffected women

1 reference

12 December 2020

10.1007/S11764-008-0077-7

Identifiers

DOI

1 reference

20 August 2017

1 reference